MAS vs STRO
Masco Corporation (MAS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MAS and STRO stock pages for the full models.
Not investment advice.